Patient outcomes appeared to be more heavily driven by breast cancer stage than delays in diagnosis, researchers found.

The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute ...

I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

In the event of an opioid emergency, the right medicine could be the difference between life and death when every second ...

Real-time observation of certain biochemical processes in blood vessels from mice has revealed a previously unknown ...

Hypertension is typically treated with medications like diuretics, ACE inhibitors, beta-blockers, calcium channel blockers, ...

Weight loss jabs such as Wegovy are “lifelong treatments” and most people who stop taking them will lose the effects, a ...

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in ...

Eli Lilly’s CEO Dave Ricks cited stocking levels and unexpected market dynamics in Q4 2024 in the GLP-1RA market.

For the people it affects (and anyone who shares a bed with them) restless legs syndrome (RLS) is a torturous condition.

Taken together with Keros’ recent pivot away from obesity, the termination of its pulmonary arterial hypertension study could ...

We've never been closer to accurately assessing whether an individual is more susceptible to developing major depressive ...